Skip to main content

Table 6 Safety Outcomes

From: Design of the exhale airway stents for emphysema (EASE) trial: an endoscopic procedure for reducing hyperinflation

1

Major hemoptysis: ≥200 mL estimated blood loss or requiring transfusion, or requiring arterial embolization, or surgical/endoscopic intervention

2

Respiratory failure requiring mechanical ventilation ≥24 hours

3

Pulmonary infection or COPD exacerbation requiring hospitalization >7 days

4

Pneumothorax requiring tube drainage >7 days

5

Death within 30 days of device implantation or the initial hospitalization if longer than 30 days, and death from respiratory causes